Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sanjita Chittimoju"'
Publikováno v:
Case Reports in Endocrinology, Vol 2022 (2022)
Background. SARS-CoV-2 has been known to cause multisystemic involvement, gaining entry through ACE-2 and TMPRSS2 receptors. COVID-19 vaccine-associated thyroiditis cases are now being reported. Case Report. Case 1. A 36-year-old woman with a history
Externí odkaz:
https://doaj.org/article/baca4e076fdc47d9a2a2793baa08f0df
Autor:
Cristiane J Gomes-Lima, Sanjita Chittimoju, Leen Wehbeh, Sunita Dia, Prathyusha Pagadala, Mohammad Al-Jundi, Sakshi Jhawar, Eshetu Tefera, Mihriye Mete, Joanna Klubo-Gwiezdzinska, Douglas Van Nostrand, Jacqueline Jonklaas, Leonard Wartofsky, Kenneth D Burman
Publikováno v:
Journal of the Endocrine Society. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1749f113c710c4829a140547636f3630
https://doi.org/10.1210/jendso/bvad005
https://doi.org/10.1210/jendso/bvad005
Autor:
Cristiane J Gomes-Lima, Sanjita Chittimoju, Leen Wehbeh, Sunita Dia, Prathyusha Pagadala, Mohammad Al-Jundi, Sakshi Jhawar, Eshetu Tefera, Mihriye Mete, Joanna Klubo-Gwiezdzinska, Douglas Van Nostrand, Jacqueline Jonklaas, Leonard Wartofsky, Kenneth D Burman
Publikováno v:
Journal of the Endocrine Society. 6
Context Recombinant human thyrotropin (rhTSH) is currently not Food and Drug Administration approved for the treatment of high-risk patients with differentiated thyroid cancer (DTC). Objective The goal of our study was to compare the outcomes in high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff17998fe89ad36816caca6dccb06fd3
https://doi.org/10.1210/jendso/bvac032
https://doi.org/10.1210/jendso/bvac032
Autor:
Cristiane J, Gomes-Lima, Sanjita, Chittimoju, Leen, Wehbeh, Sunita, Dia, Prathyusha, Pagadala, Mohammad, Al-Jundi, Sakshi, Jhawar, Eshetu, Tefera, Mihriye, Mete, Joanna, Klubo-Gwiezdzinska, Douglas, Van Nostrand, Jacqueline, Jonklaas, Leonard, Wartofsky, Kenneth D, Burman
Publikováno v:
Journal of the Endocrine Society. 6(5)
Recombinant human thyrotropin (rhTSH) is currently not Food and Drug Administration approved for the treatment of high-risk patients with differentiated thyroid cancer (DTC).The goal of our study was to compare the outcomes in higher-risk patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9730a51bc86387822071380572c07a57
https://pubmed.ncbi.nlm.nih.gov/35356009
https://pubmed.ncbi.nlm.nih.gov/35356009